Lazar Dimitrov
Directeur/Membre du Conseil chez Lumos Pharma Sub, Inc.
Provenance du réseau au premier degré de Lazar Dimitrov
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX.
9
| Subsidiary | Medical/Nursing Services | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lazar Dimitrov via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| IBEX TECHNOLOGIES | Medical Specialties | Founder | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Corporate Officer/Principal | |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Ziarco, Inc. | Director/Board Member | ||
| GALERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Drexel University | College/University | Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| New York University | College/University | Corporate Officer/Principal | |
| University of California San Diego | College/University | Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| BLACKSTONE INC. | Investment Managers | Private Equity Investor | |
| North Carolina State University College of Sciences Foundation | Corporate Officer/Principal | ||
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | Investment Managers | Private Equity Investor | |
| UCSF School of Medicine | College/University | Corporate Officer/Principal | |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| SAVARA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Silk Technologies Ltd.
 Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | Pharmaceuticals: Major | Director/Board Member | |
Ophthalmology Innovation Summit
 Ophthalmology Innovation Summit Financial ConglomeratesFinance Ophthalmology Innovation Summit provides investment services. The private company is based in Jericho. The American company was founded by Emmett T. Cunningham, Gilbert H. Kliman. | Financial Conglomerates | Founder | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Pr3vent, Inc
 Pr3vent, Inc Medical/Nursing ServicesHealth Services Pr3vent, Inc provides healthcare technology services. The company was founded by Jochen Kumm and Darius M. Moshfegh and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Founder | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Shape Therapeutics, Inc. operates as a biotechnology firm. It offers genome medicine. The company was founded by Francois Vigneault and John D. Suliman in 2018 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Francis I Proctor Foundation | Corporate Officer/Principal | ||
Code Biotherapeutics, Inc.
 Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Sorriso Pharmaceuticals, Inc.
 Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Director/Board Member | |
Placid0, Inc.
 Placid0, Inc. Packaged SoftwareTechnology Services Part of Ainsly Ltd., Placid0, Inc. develops a mobile platform for assessing ocular conditions. The company is based in Pasadena, CA. The company was founded in 2020 by Andrew Moshfeghi, Zach Bodnar, Darius M. Moshfeghi, Jochen Kumm, Emmett T. Cunningham. Placid0 was acquired by Ainsly Ltd. on February 10, 2022. | Packaged Software | Founder | |
| New Enterprise Associates, Inc. | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 46 |
| Canada | 5 |
| Espagne | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 8 |
| Finance | 8 |
| Commercial Services | 2 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 135 |
| Independent Dir/Board Member | 40 |
| Corporate Officer/Principal | 23 |
| Chairman | 18 |
| Founder | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Emmett Cunningham | 29 |
| Carole Nüchterlein | 26 |
| Kevin Lalande | 24 |
| Richard Hawkins | 21 |
| Cameron Wheeler | 20 |
| Robert A. Heft | 18 |
| An van Es-Johansson | 13 |
| Emmanuel Lacroix | 10 |
- Bourse
- Insiders
- Lazar Dimitrov
- Connexions Sociétés
